## LMT: Lockheed Martin Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -0.3% below STRENGTH zone (4.0-10.0%); PEG 1.54 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($448.98)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Lockheed Martin Secures US$1 Billion Pentagon Deal for 198 F-35s**
- Source: Mexico Business News | 20251208T185800 | Bullish | Relevance: 99%
-  Lockheed Martin has been awarded a US$1.14 billion contract modification by the US Department of War to procure materials for 198 F-35 fighter jets across Lot 20 and Lot 21 production. This deal focuses on long-lead materials to ensure timely delivery for US military branches, FMS customers, and cooperative program partners. The majority of the work will be performed at Lockheed Martin's Fort Worth, Texas facility, with a projected completion date of December 2030.

**2. Lockheed Martin Stock Falls 6% in Six Months: What Should You Do?**
- Source: Finviz | 20251208T141641 | Neutral | Relevance: 99%
- Lockheed Martin's shares have underperformed the Zacks Aerospace-Defense industry over the past six months, declining 6% due to skilled labor shortages and losses on fixed-price programs. Despite these challenges, the company boasts a strong backlog of $179.1 billion from major contract wins, supported by growth in key programs and strategic investments in hypersonics and advanced simulation. While new investors might consider waiting for a better entry point, current holders could retain the stock given its earnings growth projections and superior return on invested capital.

**3. Lockheed Martin Corp -On Dec 5 Entered Into New 364-Day Revolving Credit Agreement - SEC Filing**
- Source: TradingView | 20251209T224620 | Somewhat-Bullish | Relevance: 99%
-  Lockheed Martin Corp (LMT) announced it has entered into a new 364-day revolving credit agreement on December 5. This agreement includes a $3.0 billion unsecured revolving credit facility and is set to mature on December 4, 2026, with an option for a term loan.

**4. Lockheed Martin Wins $1.141B Navy Contract to Advance 198 F-35s Into Production**
- Source: Security Clearance Jobs | 20251208T150813 | Bullish | Relevance: 98%
-  Lockheed Martin Aeronautics Co. has been awarded a $1.141 billion modification to a previously awarded contract. This funding will procure long lead materials, parts, and components for 65 Lot 20 and 133 Lot 21 F-35 production aircraft for the Air Force, Navy, Marine Corps, F-35 cooperative program partners, and Foreign Military Sales customers. The work is expected to be completed by December 2030, with various fiscal year funds being obligated at the time of award.

**5. Hensoldt partners with Lockheed Martin for German naval systems**
- Source: Investing.com | 20251209T090855 | Bullish | Relevance: 98%
- Hensoldt will act as Lockheed Martin Canadaâ€™s German-based contractor to integrate the CMS 330 combat management system into German naval platforms, with work commencing in early 2026. This system aims to boost the capabilities of German naval vessels by enhancing real-time situational awareness and coordinated decision-making. The partnership underscores a strategic collaboration to improve operational effectiveness through advanced technological integration.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.00M) |
| Sells | 7 ($1.59M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- State Street Corpora: 14.8% (-1.0%)
- Vanguard Group Inc: 9.2% (-1.9%)
- Blackrock Inc.: 7.3% (-2.4%)
- Charles Schwab Inves: 3.7% (+8.6%)
- Morgan Stanley: 2.2% (-2.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.54 elevated, pricing in significant growth expectations. Forward P/E 16.1x attractive for 31% earnings growth. Quality metrics strong (ROE 63%). Balance sheet: $3.3B free cash flow. Insider selling cluster ($1.6M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $109.2B |
| Beta | 0.24 |
| 52W Range | $410.11 - $516.00 |
| Short Interest | 1.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.54 |
| Forward P/E | 16.1 |
| Current P/E | 21.1 |
| YoY Growth | 31.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -4.0% to -0.3% (+3.7% in 5 days), confirming momentum buildup. Below STRENGTH zone by 4.3pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.3%) - potential reversal signal. MACD histogram positive (2.65), confirming momentum. RSI neutral at 54.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.35% (CS: 50) | Neutral |
| RSI_14 | 54.0 | Neutral |
| MACD Histogram | 2.65 | Bullish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 0.979x | Below |
| vs SMA200 | 1.007x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $467.94
- **Stop Loss:** $448.98 (4.1% risk)
- **Target:** $486.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 52
- **Position Value:** $24,332.88
- **Portfolio %:** 24.33%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2026-01-27 (Est: $6.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.35 | $6.95 | +9.4% |
| 2025Q2 | $6.47 | $1.46 | -77.4% |
| 2025Q1 | $6.32 | $7.28 | +15.1% |
| 2024Q4 | $6.62 | $7.71 | +16.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*